Urgosedin inhibits hypotension, hypoglycemia, and pro-inflammatory mediators induced by lipopolysaccharide. [electronic resource]
Producer: 20050104Description: 363-71 p. digitalISSN:- 0160-2446
- Administration, Oral
- Adrenergic alpha-Antagonists -- administration & dosage
- Animals
- Aorta, Thoracic -- drug effects
- Benzene Derivatives -- administration & dosage
- Blood Glucose
- Cell Line
- Cytokines -- adverse effects
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical -- methods
- Gene Expression Regulation, Enzymologic -- drug effects
- Heart Rate -- drug effects
- Hypoglycemia -- chemically induced
- Hypotension -- chemically induced
- Inflammation Mediators -- antagonists & inhibitors
- Injections, Intraperitoneal
- Injections, Intravenous
- Lipopolysaccharides -- administration & dosage
- Mice
- Mice, Inbred ICR
- Muscle Contraction -- drug effects
- Muscle, Smooth, Vascular -- drug effects
- Nitric Oxide Synthase -- antagonists & inhibitors
- Nitric Oxide Synthase Type II
- Norepinephrine -- pharmacology
- Piperazines -- administration & dosage
- Prodrugs -- adverse effects
- Rats
- Rats, Wistar
- Serotonin -- pharmacology
- Serotonin Agents -- administration & dosage
- Toxicity Tests, Acute -- methods
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.